Wuxi Biologics (Cayman)'s market cap is currently ―. The company's EPS TTM is $0.115; its P/E ratio is 15.94; Wuxi Biologics (Cayman) is scheduled to report earnings on August 19, 2024, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Dec 21	Jun 21	Dec 20	Jun 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 9.86B	¥ 11.13B	¥ 13.94B	¥ 8.48B	¥ 5.38B
Total Assets	¥ 47.47B	¥ 44.03B	¥ 43.58B	¥ 28.96B	¥ 20.72B
Total Debt	¥ 4.40B	¥ 4.30B	¥ 4.60B	¥ 3.33B	¥ 3.68B
Net Debt	¥ -5.47B	¥ -6.83B	¥ -9.34B	¥ -5.15B	¥ -1.69B
Total Liabilities	-	¥ 11.33B	¥ 10.00B	¥ 8.06B	¥ 6.95B
Stockholders Equity	¥ 34.46B	¥ 32.28B	¥ 33.22B	¥ 20.56B	¥ 13.63B
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in CNY

Wuxi Biologics (Cayman) Earnings and Revenue History

Income Statement >

Wuxi Biologics (Cayman) Debt to Assets

Balance Sheet >

Wuxi Biologics (Cayman) Cash Flow

Cash Flow >

Wuxi Biologics (Cayman) Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing